244 results
8-K
EX-99.1
RGEN
Repligen Corp.
21 Feb 24
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
7:47am
Costs and expenses:
Cost of product revenue
Research and development
Selling, general and administrative
Contingent consideration
(Loss) Income from
8-K
EX-99.1
k9ta2z7bu4 a35
31 Oct 23
Repligen Reports Third Quarter 2023 Financial Results
7:48am
8-K
EX-10.1
w66s s6r6ab15t
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
EX-99.1
mwbogru cq
2 Aug 23
Repligen Reports Second Quarter 2023 Financial Results
7:54am
8-K
EX-99.1
hq58 ambtqp3
2 May 23
Repligen Reports First Quarter 2023 Financial Results
7:48am
8-K
EX-99.1
au2l3o517li4r9f87oyf
1 Nov 22
Repligen Reports Third Quarter 2022 Financial Results
7:54am
8-K
EX-10.1
rwgo9
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
8-K
EX-99.1
ba3f0e1uwyp46
27 Apr 22
Repligen Reports First Quarter 2022 Financial Results
7:47am